These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28798269)

  • 1. Regarding "Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging".
    Macbeth F; Treasure T
    Oncologist; 2017 Nov; 22(11):1411. PubMed ID: 28798269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E; Mihailović J; Nikoletić K; Srbovan D
    Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
    Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
    Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
    Liong SY; Kochhar R; Renehan AG; Manoharan P
    ANZ J Surg; 2012 Oct; 82(10):729-36. PubMed ID: 22989147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer.
    Fiocchi F; Iotti V; Ligabue G; Malavasi N; Luppi G; Bagni B; Torricelli P
    Clin Imaging; 2011; 35(4):266-73. PubMed ID: 21724118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
    Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
    Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels.
    Li W; Yin W; Ou R; Chen T; Xiong L; Cheng D; Xie D; Zheng X; Xu Y; Zhao L
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):675-81. PubMed ID: 26497700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application and Indication of Carcinoembryonic Antigen Triggered 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Detection of Relapse of Colorectal Cancer Patients After Curative Therapy.
    Yu X; Zhu L; Dai D; Song X; Chen W; Zhu Y; Li X; Xu W
    J Comput Assist Tomogr; 2017; 41(5):719-725. PubMed ID: 28481810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of recurrent colorectal cancer with positron emission tomography.
    Haji A
    Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
    Watson AJ; Lolohea S; Robertson GM; Frizelle FA
    Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new imaging technique for colorectal cancer: positron emission tomography.
    Flamen P; Van Cutsem E; Mortelmans L
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
    [No Abstract]   [Full Text] [Related]  

  • 14. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
    Chessin DB; Kiran RP; Akhurst T; Guillem JG
    J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
    Ozkan E; Soydal C; Araz M; Aras G
    Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
    Culverwell AD; Chowdhury FU; Scarsbrook AF
    Abdom Imaging; 2012 Dec; 37(6):1021-31. PubMed ID: 22371087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
    Hansen AF; Jensen MR; Nordholm-Carstensen A
    Ugeskr Laeger; 2016 Sep; 178(37):. PubMed ID: 27649583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic response using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography and the change in the carcinoembryonic antigen level for predicting response to pre-operative chemoradiotherapy in patients with rectal cancer.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song JY; Jeong JU; Nam TK
    Radiother Oncol; 2011 Jan; 98(1):134-8. PubMed ID: 21040991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.